Product Launch Webinar: Examining your EU and UK Product Launch Supply Chain Post Brexit
This webinar provides an overview of key supply chain milestones and post-Brexit considerations for planning your EU supply chain strategy.
Emma Jordan, Logistics Manager, applies her wealth of experience and highlights some of the practical considerations of setting up your supply chain to get your drug to market. From examining finance and customs, the various supply chain models and even the regulations that govern your supply chain.
Reviewing the ‘Northern Ireland Protocol’, a key part of the UK’s Withdrawal Agreement with the EU, Ivan Waide (Corporate Counsel, Almac Group) joins Emma to provide insight into the Protocol, how it puts Almac’s global headquarters in Craigavon, Northern Ireland, in a unique position (with access to both the EU and UK markets) and its impact on the supply chain and movement of pharmaceutical drug products within Northern Ireland, GB and EU27.
Speakers: Emma Jordan, Logistics Manager and Ivan Waide, Head of Patents & Licensing
View Resource
Commercial Services
Almac Pharma Services provide a wide range of customised commercial services from supporting product launch, manufacturing and / or packaging drug product, to securing supply chain with global serialisation solutions.
Our flexible, quality-led commercial solutions range from orphan drug launches to ongoing high-volume commercial product manufacture, packaging and supply.
